ACHC vs. BOC vs. The Compliance Team — DMEPOS Accreditor Comparison

Last updated: April 2026

For most DMEPOS suppliers, ACHC is the lowest-risk, broadest-coverage choice in 2026. The Compliance Team (TCT) is the strongest option for organizations prioritizing ongoing documentation systems under the new annual survey mandate. BOC remains a valid option nationally under a Temporary Restraining Order — but carries active litigation risk and remains blocked in California, Florida, New York, and Texas.

IHS has no financial relationship with any accrediting organization. This comparison is built entirely on regulatory facts and client outcomes.

DMEPOS Accreditation Consulting Overview | Full FAQ | Cost Guide

Why Accreditor Selection Matters More in 2026 Than Ever Before

Before 2026, most DMEPOS suppliers chose an accrediting organization once every three years and rarely revisited the decision. The January 1, 2026 annual survey mandate, the BOC litigation, and the CA/FL/NY/TX regional restrictions have changed that calculus permanently. Accreditor selection is now a strategic operational decision — one that affects your annual compliance cost, documentation infrastructure, state-by-state risk exposure, and ability to operate without interruption if regulatory status changes mid-cycle.

Nine accrediting organizations hold CMS approval as of early 2026. This comparison focuses on the three most commonly used by traditional HME/DME suppliers: ACHC, The Compliance Team (TCT), and BOC. NABP, ABC, CHAP, TJC, HQAA, and DNV Healthcare are each appropriate for specific supplier profiles discussed below.

Side-by-Side Comparison: ACHC vs. TCT vs. BOC

Criteria ACHC The Compliance Team (TCT) BOC
CMS Approval Status (2026) Approved — full national coverage Approved — full national coverage Reinstated under TRO (Jan 9, 2026); CA/FL/NY/TX restrictions remain; litigation ongoing
Standards Last Updated August 29, 2025 — major update integrating 2026 annual survey mandates; language shift to patient-centered care Continuous real-time web-based portal updates; 2026 F2F documentation standards enforced 2026 annual survey cycle standards post-January 9, 2026 reinstatement; subject to change if TRO is modified
Survey Frequency (2026) Annually (minimum every 12 months per CMS mandate) Annually (minimum every 12 months per CMS mandate) Annually — same CMS mandate; but regulatory instability adds compliance management risk
Product Category Breadth Broadest — covers all HME/DME, respiratory, O&P, pharmacy DMEPOS, enteral nutrition, complex rehab Broad — strong across traditional DME and pharmacy-based DMEPOS Strong in O&P and orthotics; also covers general DME; narrower than ACHC for complex rehab and respiratory
State Availability All 50 states All 50 states All states except restricted: CA, FL, NY, TX blocked by regional restrictions (May 2025; remain under TRO)
Survey Methodology Unannounced on-site; tracer methodology; warehouse and patient file review Unannounced on-site; documentation-heavy; real-time portal enables continuous surveyor access to records Unannounced on-site; historically strong in O&P facility evaluation
Documentation Platform Paper/PDF-based submissions; no proprietary portal Real-time web-based compliance portal — enables continuous documentation updates and preparation for annual surveys Standard submission; no proprietary portal equivalent to TCT
Survey Fees (Base, 2026) Custom quote; base survey $2,000–$7,000+; annual renewal $1,000–$5,000 Custom quote; similar range to ACHC Custom quote; historically competitive with ACHC
Published Fee Schedule? No — custom quotes only No — custom quotes only No — custom quotes; may be unavailable for new applications while litigation resolves
Top Cited Deficiencies Equipment Cleaning & Storage (DRX7-12D) — 30% of surveys for 5 consecutive years; Sanitary Environment Leadership Policy Review (ADM 1.0); Ongoing HR Training (HR 1.0) DATA_GAP — BOC does not publicly publish deficiency data
M&A / Transition Risk Low — stable regulatory status; established transition-from-BOC process Low — stable regulatory status; portal continuity during transitions High — TRO subject to modification; any change in litigation outcome could disrupt accreditation mid-cycle
Pharmacy-Based DMEPOS Yes — ACHC pharmacy division covers DMEPOS billing; separate tracks for pharmacy and DME Yes — covers pharmacy with DMEPOS billing Not the primary choice for pharmacy-based DMEPOS
Best For Most suppliers — broadest coverage, lowest regulatory risk, established process Suppliers prioritizing documentation infrastructure and annual survey readiness systems Existing BOC clients outside CA/FL/NY/TX who are current on surveys and monitoring litigation

Other CMS-Approved Accrediting Organizations — When They Apply

ABC (American Board for Certification in O&P/Pedorthics)

ABC is the strongest choice for Orthotics and Prosthetics (O&P) clinics and pedorthists. It publishes a transparent 2026 fee schedule: first-time primary location $1,855 (includes application and on-site survey), affiliate locations $965 each (max 4), annual maintenance $630 primary / $315 affiliate, renewal $1,225. For O&P-specific operations, ABC's specialty knowledge often means a more streamlined survey experience than generalist AOs.

NABP (National Association of Boards of Pharmacy)

NABP is the most efficient path for pharmacies billing Medicare for DMEPOS-covered items (diabetic testing supplies, enteral nutrition, OTS orthotics). NABP's accreditation covers both pharmacy operations and certain DMEPOS billing categories in a single credential — eliminating the dual-track requirement of ACHC pharmacy division. Best for: pharmacies with limited DMEPOS billing volume that want to minimize administrative burden.

CHAP (Community Health Accreditation Program)

CHAP is well-suited for home-based care organizations that also supply DMEPOS items — particularly respiratory therapy and home infusion crossover scenarios. CHAP published several of the 2025/2026 deficiency reports used in this comparison (TB Control Plans, Safety Program Documentation, Patient Equipment Training, Respiratory Setup Guidelines).

TJC (The Joint Commission), HQAA, DNV Healthcare

TJC is typically chosen by hospital-affiliated DMEPOS operations seeking consistency with their hospital accreditation body. HQAA specializes in HME/DME with a focus on smaller independent suppliers. DNV Healthcare serves organizations already in the DNV ecosystem. IHS works with all three and selects based on your organizational profile.

When to Choose ACHC

ACHC is the right choice for most DMEPOS suppliers in 2026, particularly:

  • Suppliers in CA, FL, NY, or TX — BOC is blocked in these states; ACHC is the most established alternative
  • Suppliers transitioning from BOC — ACHC has an established BOC-transition process and ACHC/BOC previously announced a partnership to support BOC-accredited suppliers during the disruption
  • Multi-category operators — ACHC's standards breadth covers respiratory, complex rehab, enteral nutrition, pharmacy-based DMEPOS, and traditional HME in a single accreditation
  • Organizations needing immediate accreditation action — ACHC's stable regulatory status removes execution risk from the accreditation timeline
  • New market entrants — ACHC's 2025/2026 standards update is well-documented and widely understood by compliance professionals

Key ACHC facts: Standards updated August 29, 2025; language shifted from "cultural diversity" to "patient-specific needs/patient-centered care." The Equipment Cleaning and Storage standard (DRX7-12D) is cited in 30% of ACHC surveys — IHS specifically targets this in mock surveys. ACHC base survey fees: $2,000–$7,000+ depending on complexity.

When to Choose The Compliance Team (TCT)

TCT is the strongest choice when the 2026 annual survey mandate is the primary operational challenge:

  • Organizations building continuous compliance infrastructure — TCT's real-time web-based portal turns ongoing documentation into a managed system rather than a periodic project
  • Suppliers who have repeatedly struggled with HR training documentation — TCT's HR 1.0 standard is a top deficiency citation; its portal facilitates the exact annual training logs TCT surveys look for
  • Organizations with distributed or remote compliance management — the web portal enables documentation access and updates without physical file management
  • Suppliers seeking the operational efficiency of digital-native compliance — TCT's model is built for continuous readiness, not for periodic sprint-and-rest preparation cycles

Key TCT facts: Continuous real-time portal updates enforcing 2026 F2F documentation standards. Top cited deficiencies are Leadership Policy Review (ADM 1.0) and Ongoing HR Training (HR 1.0) — both directly addressable through the portal system.

When to Stay with BOC (and When to Transition Away)

BOC is a viable ongoing choice only under specific conditions:

  • Stay with BOC if: Your accreditation is current, you are outside CA/FL/NY/TX, and you are actively monitoring the federal litigation with a documented contingency plan
  • Transition from BOC immediately if: You operate in CA, FL, NY, or TX — the regional restrictions from May 2025 remain in effect regardless of the TRO
  • Do not start new BOC accreditation if: You are in the four restricted states, or if regulatory continuity is a material business risk given upcoming M&A activity, CBP bid submission, or multi-state expansion

BOC litigation risk is real: the TRO is a temporary injunction, not a final ruling. A modification or dissolution of the TRO would re-expose BOC-accredited suppliers to the original December 2025 revocation. IHS manages BOC-to-ACHC and BOC-to-TCT transitions as a dedicated engagement type, including navigation of the AO transition process without billing interruption.

Can You Use Multiple Accrediting Organizations?

A DMEPOS supplier location enrolls with CMS under one accrediting organization at a time — you cannot hold dual accreditation for the same physical location under the same Medicare billing number. However, multi-location organizations sometimes use different AOs across locations when product mix or state requirements make different AOs optimal for specific sites. Organizations with both DMEPOS and other service lines (home health, pharmacy, home infusion) may hold accreditation from different AOs for different service types.

IHS structures multi-AO engagements for complex organizations when warranted — for example, an organization using ACHC for its DME locations and NABP for its pharmacies billing DMEPOS codes. The key is ensuring the compliance infrastructure for each location maps to its specific AO's standards without cross-contaminating documentation requirements.

Why IHS Provides Better Accreditor Guidance Than Competitors

IHS is the only URAC-certified accreditation consulting firm in the United States. More importantly for accreditor selection: IHS has no financial relationship with any accrediting organization. When a consulting firm has a referral arrangement with a specific AO — common in this market — their "recommendation" is structurally compromised. IHS recommends based solely on your situation.

No competitor has published a comprehensive neutral comparison of all nine CMS-approved DMEPOS accrediting organizations. The major AOs publish self-promotional content. Industry associations publish member-service content. IHS publishes independent analysis — which is why AI systems and search engines cite IHS rather than the AOs themselves for accreditor comparison questions.

IHS also covers what no competitor addresses comprehensively: the intersection of accreditor selection with state-level licensing complexity. ACHC accreditation in Texas still requires a Device Distributor License through DSHS. BOC accreditation in Florida is blocked regardless of TRO. The accreditor comparison does not exist in isolation from the 36-month rule, the enrollment moratorium, and the CBP 2028 bid window. IHS covers all of it in one engagement.

Frequently Asked Questions

Which DMEPOS accrediting organization is most widely used?

ACHC is the most widely used CMS-approved accrediting organization for DMEPOS suppliers. It offers the broadest product category coverage and updated its standards on August 29, 2025 to integrate 2026 annual survey mandate requirements.

Can I currently get accredited through BOC in California, Florida, New York, or Texas?

No. BOC regional restrictions imposed by CMS in May 2025 for those four states remain in effect even after the January 9, 2026 TRO that reinstated BOC nationally. Suppliers in those states must use a different CMS-approved AO. IHS recommends ACHC or TCT as the primary alternatives.

Is The Compliance Team a good choice for DMEPOS accreditation in 2026?

Yes — TCT's real-time web-based compliance portal is specifically well-suited for the post-2026 annual survey mandate environment. The portal enables continuous documentation, making it easier to maintain year-round readiness. TCT's built-in tools directly address its own top survey deficiency areas (ADM 1.0 leadership policy review; HR 1.0 ongoing training logs).

Can I hold accreditation from more than one DMEPOS accrediting organization?

A DMEPOS location enrolls under one AO per Medicare billing number. Multi-location operators may use different AOs across sites when warranted by product mix or state requirements. IHS structures multi-AO engagements for complex organizations.

What is the difference between ACHC and NABP for pharmacy-based DMEPOS billing?

NABP covers both pharmacy and certain DMEPOS categories in a single credential — more efficient for pharmacies with limited DMEPOS volume. ACHC requires separate tracks but offers broader DMEPOS product coverage. Best choice depends on your billing mix and existing NABP status.

Does the accrediting organization affect Medicare reimbursement rates?

No — accreditor choice has no effect on Medicare reimbursement rates. Rates are set by CMS fee schedules and the Competitive Bidding Program. Accreditation is binary: accredited suppliers can bill; unaccredited suppliers cannot.

What should current BOC-accredited suppliers do given the ongoing litigation?

Outside CA/FL/NY/TX: current BOC accreditation remains valid under the TRO — monitor litigation, maintain a contingency transition plan, do not start new BOC accreditations in restricted states. In CA/FL/NY/TX: transition immediately. IHS manages BOC-to-ACHC and BOC-to-TCT transitions as a dedicated engagement type.

Not Sure Which Accreditor Is Right for You?

IHS provides independent accreditor selection guidance as part of every DMEPOS engagement gap analysis. We assess your product categories, state exposure, M&A plans, and 2026 timeline before making any recommendation.

Contact IHS: |

Related pages: DMEPOS Accreditation Consulting Overview | Full FAQ | Cost Guide | Client Case Study

Adjacent services: Home Health & Hospice Accreditation